Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/25/2025

Diagnosis and Treatment of Male Penile Discharge

Diagnostic Confirmation

  • A sexually active male presenting with penile discharge should be treated empirically with ceftriaxone 250 mg IM plus doxycycline 100 mg orally twice daily for 7 days to cover both gonorrhea and chlamydia, as these are the two primary bacterial pathogens responsible for urethritis, according to the Centers for Disease Control and Prevention (CDC) 1
  • Mucopurulent or purulent discharge is a diagnostic criterion for urethritis 1
  • A Gram stain showing ≥5 polymorphonuclear leukocytes per oil immersion field in urethral secretions is a diagnostic criterion for urethritis, as recommended by the CDC 1, 2
  • Obtain nucleic acid amplification tests (NAAT) for both N. gonorrhoeae and C. trachomatis on first-void urine or urethral swab, as these tests have sensitivities of 86.1%-100% and specificities of 97.1%-100%, according to the CDC 1

First-Line Empiric Treatment

  • The CDC recommends ceftriaxone 250 mg IM single dose plus doxycycline 100 mg orally twice daily for 7 days as the first-line empiric treatment for gonorrhea and chlamydia 1, 3
  • This combination addresses the two most important bacterial pathogens and prevents complications including epididymitis, Reiter's syndrome, and transmission to partners, according to the CDC 1, 2

Alternative Regimens

  • Erythromycin base 500 mg orally 4 times daily for 7 days is an alternative regimen for chlamydia coverage, as recommended by the CDC 2
  • Erythromycin ethylsuccinate 800 mg orally 4 times daily for 7 days is an alternative regimen for chlamydia coverage, as recommended by the CDC 2

Additional Testing Requirements

  • The CDC recommends syphilis serology (sequential treponemal and nontreponemal antibody testing) for all patients with urethral discharge 4
  • HIV counseling and testing are recommended for all patients with urethral discharge, according to the CDC 4

Partner Management

  • Sexual partners from the 60 days preceding symptom onset must be referred for evaluation and treatment, as recommended by the CDC and the American College of Physicians 3, 4
  • Patients should abstain from sexual intercourse until both they and their partners complete treatment and are symptom-free, according to the CDC 4

Follow-Up Protocol

  • Patients must return for reevaluation if symptoms persist or recur after completing therapy, as recommended by the CDC and the American Academy of Family Physicians 2, 3
  • For persistent or recurrent urethritis, re-treat with the initial regimen if non-compliant or re-exposed to untreated partner, according to the CDC 2

REFERENCES

3

Treatment for Leukorrhea [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Treatment for Epididymitis vs Orchitis [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025